What Is Nanobiotechnology?

Nanobiotechnology is a discipline that applies the tools and principles of nanotechnology to biological systems, creating functional devices, materials, and processes that operate at the scale of individual molecules and cellular components. It draws on molecular biology, biochemistry, physics, and engineering to design structures with dimensions typically below 100 nanometers that can interact with, sense, or modify living matter in precise ways. The field consolidates two previously separate research cultures: the bottom-up synthesis tradition of chemistry and molecular biology, in which biological macromolecules self-assemble into functional architectures, and the top-down fabrication tradition of microelectronics, in which lithographic and deposition techniques are scaled toward molecular dimensions.

Nanotechnology provides the physical framework: control of matter at dimensions where quantum and surface effects dominate over bulk properties. Biology supplies the recognition machinery, including antibodies, aptamers, DNA hybridization, and enzyme catalysis, that gives nanobiotechnological devices their specificity. The IEEE Nanotechnology Council conferences on nanomedicine and nanobiotechnology bring together researchers from both traditions to translate findings from controlled laboratory conditions toward medical and industrial use.

Nanomedicine

Nanomedicine is the largest sub-area of nanobiotechnology, encompassing the design of nanoparticle drug carriers, imaging agents, and therapeutic devices intended for clinical use. Liposomes, polymeric micelles, dendrimers, and inorganic nanoparticles have all been formulated as carriers that encapsulate therapeutic molecules, extend circulation half-life, and release payloads in response to pH, temperature, or enzyme activity at target sites. The approvals of liposomal doxorubicin (Doxil) in 1995 and lipid nanoparticle mRNA carriers for COVID-19 vaccines in 2020 mark two practical milestones that demonstrated the translational viability of nanomedicine concepts. Research published through WIREs Nanomedicine and Nanobiotechnology covers active targeting, stimuli-responsive release, and the immunological challenges that arise when nanoparticles circulate in the bloodstream.

Biosensing and Diagnostics

Nanobiotechnology has produced a new class of biosensors in which biological recognition elements such as antibodies, DNA probes, or aptamers are coupled to nanostructured transducers including gold nanoparticle arrays, carbon nanotubes, and nanowire field-effect transistors. The nanoscale geometry provides a high surface-to-volume ratio that concentrates analyte capture events near the transducer surface, lowering detection limits to the femtomolar range for protein biomarkers and to the attomolar range for nucleic acid targets under optimized conditions. Lateral flow assay strips functionalized with colloidal gold nanoparticles represent the most widely deployed nanobiotechnological product, used in point-of-care testing for influenza, HIV, and SARS-CoV-2. More complex integrated platforms combine microfluidic sample handling with nanowire or nanotube sensor arrays to perform multiplexed detection of cancer-associated proteins from blood.

Nanoscale Fabrication and Biological Interfaces

Nanobiotechnology also encompasses methods for patterning biological molecules on surfaces with nanometer precision, enabling studies of how molecular arrangement affects cell signaling and adhesion. Dip-pen nanolithography, microcontact printing at nanometer pitch, and DNA origami scaffolding all allow researchers to position proteins, lipid bilayers, and nucleic acid sequences at defined locations. These patterned surfaces serve as testbeds for fundamental questions in receptor biology and as substrates for next-scale biosensor fabrication. The PMC review on nanobiomaterials and nanomedicine surveys how surface functionalization strategies govern the interaction between engineered nanostructures and the biological environment.

Applications

Nanobiotechnology has applications in a range of fields, including:

• Targeted cancer therapy using antibody-conjugated nanoparticle drug carriers
• Vaccine development with lipid nanoparticle mRNA delivery systems
• Rapid point-of-care diagnostic testing for infectious diseases
• Tissue engineering scaffolds with nanopatterned surface cues
• Gene editing delivery vehicles for CRISPR-Cas9 complexes